Alberta Transplant Applied Genomics Centre

2017 Publications

  1. Halloran PF, Famulski KS, Chang J. A probabilistic approach to histologic diagnosis of antibody-mediated rejection in kidney transplant biopsies. Am J Transplant 2017;17(1):129-39.
  2. Einecke G, Reeve J, Halloran PF. Hyalinosis lesions in renal transplant biopsies: time-dependent complexity of interpretation. Am J Transplant 2017;17(5):1346-57.
  3. Loupy A, Duong Van Huyen JP, Hidalgo LG, Reeve J, Racape M, Venner J, et al. Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection. Circulation 2017;135(10):917-35.
  4. Halloran PF, Venner JM, Famulski KS. Comprehensive analysis of transcript changes associated with allograft rejection: Combining universal and selective features. Am J Transplant 2017;17(7):1754-69.
  5. Parkes MD, Halloran PF, Hidalgo LG. Direct evidence for CD16a-mediated NK cell stimulation in antibody-mediated kidney transplant rejection. Transplant 2017;101(4):e102-e111.
  6. Reeve J, Halloran PF. Letter to the Editor. Re: Biopsy transcriptome expression profiling: proper validation is key. Lancet 2017;389(10069):600-1.
  7. Halloran PF, Potena L, Duong Van Huyen JP, Bruneval P, Leone O, Kim DH, et al. Building a tissue-based molecular diagnostic system in heart transplant rejection: the heart molecular microscope MMDx. J Heart Lung Transplant 2017;36(11):1192-200.
  8. Halloran PF, Akalin E, Aubert O, Bohmig G, Brennan D, Bromberg J, et al. Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX Study. Am J Transplant 2017;17(11):2851-62.
  9. Madill-Thomsen KS, Wiggins RC, Eskandary F, Bohmig GA, Halloran PF. The effect of cortex/medulla proportions on molecular diagnoses in kidney transplant biopsies: rejection and injury can be assessed in medulla. Am J Transplant 2017 Feb 22;17(8):2117-28.
  10. Reeve J, Bohmig GA, Eskandary F, Einecke G, Lefaucheur C, Loupy A, et al. Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes. JCI Insight 2017;2(12).
  11. Aubert O, Loupy A, Hidalgo L, Duong van Huyen JP, Higgins S, Viglietti D, Jouven X, Glotz D, Legendre C, Lefaucheur C and Halloran PF. Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients. J Am Soc Nephrol;28(6):1912-23.
  12. Eskandary F, Bond G, Kozakowski N, Regele H, Marinova L, Wahrmann M, et al. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study. Transplant 2017 Mar;101(3):631-41.
  13. Loupy A, Hidalgo LG, Duong Van-Huyen JP, Jouven X, Halloran PF. Response by Loupy et al to Letters Regarding Article, "Gene Expresion Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection". Circulation 2017;136(7):698-9.